DRUG dividend yield: 4.00%. HTGC dividend yield: 10.22%. DRUG is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in DRUG shares. Hercules Capital specializes in lending to venture-backed technology and life sciences companies. This unique focus allows it to capture higher yields than traditional BDCs. Strong origination network with leading VC firms. HTGC pays regular plus supplemental dividends, making total yield among the highest in BDC space.
DRUG is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in DRUG shares.
Hercules Capital specializes in lending to venture-backed technology and life sciences companies. This unique focus allows it to capture higher yields than traditional BDCs. Strong origination network with leading VC firms. HTGC pays regular plus supplemental dividends, making total yield among the highest in BDC space.
Is DRUG or HTGC better for dividend income in 2026?
DRUG currently offers a 4.00% yield (2.00/share/year) while HTGC offers 10.22% (1.88/share/year). HTGC provides higher current income. However, DRUG has grown its dividend faster (5% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in DRUG vs HTGC earn per year?
With $10,000 invested today: DRUG pays approximately $400/year. HTGC pays approximately $1022/year. With DRIP reinvestment over 10 years, these grow to $899/year (DRUG) and $3,064/year (HTGC).
Does DRUG or HTGC pay monthly dividends?
DRUG pays quarterly dividends. HTGC pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this DRUG vs HTGC comparison by email
Save your analysis + get weekly dividend insights. Free forever.